Novel Biomarkers For Cancer Diagnosis And Therapeutic Targeting: Insights From Multi-Cancer Studies
DOI:
https://doi.org/10.58222/juvokes.v3i2.1183Kata Kunci:
Biomarkers, Dialysis efficiency, Chronic kidney disease, Personalized nephrology, Point-of-care diagnosticsAbstrak
In this systematic review, newly identified biomarkers involve different types of cancer. Their roles are not only analysed but also their applicability in diagnostics, prognosis, and therapy. Examples of such biomarkers would be: SLC35A3 in colorectal cancer, EPYC in pancreatic carcinoma, and ANKRD1 in multiple cancers suggest high potential for the enhancement of diagnosis and treatment in cancer. For instance, with CRC patients, SLC35A3 has poor survival rates, and in pancreatic cancer, EPYC is associated with cancer progression through the PI3K-AKT pathway. SLC35A3, EPYC exist as potential and new immune-related biomarkers in colorectal cancer, including B7H4, the IFN-γ/B7H4 axis, which may have contributions to better future outcomes of immunotherapy by targeting immune evasion mechanisms. For instance, the cross-cancer biomarkers ATP6AP1 and SIGLEC-15 have been discovered, and, indeed, have more therapeutic implications across so many cancer types. In this review, the findings from multi-cancer studies have been integrated to demonstrate the potential of such cross-disciplinary biomarkers in personalized medicine as part of improved patient care outcomes.
Referensi
Lu, S., Sun, X., Tang, H., Yu, J., Wang, B., Xiao, R., ... & Rao, B. (2024). Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis. Scientific Reports, 14(1), 329.
Yang, Y., Yang, C., Yang, Q., Lu, S., Liu, B., Li, D., ... & Zhou, J. (2024). Elucidating Hedgehog pathway's role in HNSCC progression: insights from a 6-gene signature. Scientific Reports, 14(1), 4686.
VSong, H. S., Ha, S. Y., Kim, J. Y., Kim, M., & Choi, J. H. (2024). The effect of genetic variants of SLC22A18 on proliferation, migration, and invasion of colon cancer cells. Scientific Reports, 14(1), 3925.
Greathouse, K. L., Stone, J. K., Vargas, A. J., Choudhury, A., Padgett, R. N., White, J. R., ... & Harris, C. C. (2024). Co-enrichment of cancer-associated bacterial taxa is correlated with immune cell infiltrates in oesophageal tumor tissue. Scientific Reports, 14(1), 2574.
Xiao, Y., Lin, H., Li, J., & Wu, J. (2024). Disulfide Ptosis-related prognostic signature correlates with immunotherapy response in colorectal cancer. Scientific Reports, 14(1), 81.
Bixby, B., Vrba, L., Lenka, J., Oshiro, M. M., Watts, G. S., Hughes, T., & Nelson, M. A. (2024). Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid. Scientific Reports, 14(1), 2939
Xu, X., Zhong, D., Wang, X., Luo, F., Zheng, X., Feng, T., ... & Ma, G. (2024). Pan-cancer integrated analysis of ANKRD1 expression, prognostic value, and potential implications in cancer. Scientific Reports, 14(1), 5268.
Juratli, M. A., Pollmann, N. S., Oppermann, E., Mohr, A., Roy, D., Schnitzbauer, A., ... & Struecker, B. (2024). Extracellular vesicles as potential biomarkers for diagnosis and recurrence detection of hepatocellular carcinoma. Scientific reports, 14(1), 5322.
Yang, Y., Yang, C., Yang, Q., Lu, S., Liu, B., Li, D., ... & Zhou, J. (2024). Elucidating Hedgehog pathway's role in HNSCC progression: insights from a 6-gene signature. Scientific Reports, 14(1), 4686.
Xiao, Y., Lin, H., Li, J., & Wu, J. (2024). Disulfide Ptosis-relatedS prognostic signature correlates with immunotherapy response in colorectal cancer. Scientific Reports, 14(1), 81.
Jing, Z. L., Liu, G. L., Zhou, N., Xu, D. Y., Feng, N., Lei, Y., ... Deng, Y. J. (2024). Interferon-γ in the tumor microenvironment promotes the expression of B7H4 in colorectal cancer cells, thereby inhibiting cytotoxic T cells. Scientific Reports, 14(1), 6053.
Zhang, S., Wang, Y., Zhang, X., Wang, M., Wu, H., Tao, Y., ... & Gao, W. (2024). ATP6AP1 as a potential prognostic biomarker in CRC by comprehensive analysis and verification. Scientific Reports, 14(1), 4018.
Qi, L., Jiang, K., Zhao, F. F., Ren, P., & Wang, L. (2024). Identification of therapeutic targets and prognostic biomarkers in the Siglec family of genes in tumor immune microenvironment of sarcoma. Scientific Reports, 14(1), 577.
Lei, H., Liao, J., Wang, X., Huang, R., Ying, C., & Yang, J. (2024). ALDH2 is a novel biomarker and exerts an inhibitory effect on melanoma. Scientific Reports, 14(1), 4183.
Hsin-Yao Wang, Wan-Ying Lin , Chenfei Zhou, Zih-Ang Yang, Sriram Kalpana and Michael S. Lebowitz. Integrating Artificial Intelligence for Advancing Multiple-Cancer Early Detection via Serum Biomarkers: A Narrative Review.
_1.png)
